Complete peritonectomy and intraperitoneal chemotherapy for recurrent rectal cancer with peritoneal metastasis

Research output: Contribution to journalArticlepeer-review

Abstract

A 68-year-old man underwent laparoscopic low anterior resection for rectal carcinoma in December 2006. Nearly 19 mo after the operation, he developed recurrent rectal cancer with peritoneal metastasis. In September 2008, he subsequently underwent a laparotomy with a peritonectomy, omentectomy, splenectomy, and a Hartmann procedure. Hyperthermic intraperitoneal oxaliplatin 750 mg was administered. The patient was discharged with no postoperative complications and has been well with postoperative FOLFOX chemotherapy.

Original languageEnglish
Pages (from-to)756-757
Number of pages2
JournalWorld Journal of Gastroenterology
Volume15
Issue number6
DOIs
StatePublished - 14 Feb 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Peritoneal metastasis
  • Peritonectomy
  • Recurrent rectal cancer

Fingerprint

Dive into the research topics of 'Complete peritonectomy and intraperitoneal chemotherapy for recurrent rectal cancer with peritoneal metastasis'. Together they form a unique fingerprint.

Cite this